Beijing Saimo Technology (HKG:2571) launched its initial public offering in Hong Kong, seeking to raise as much as HK$600 million.
The company designs and carries out R&D of ICV simulation testing and offers 33,333,400 H shares at HK$12.0 to HK$18.0 apiece.
Beijing Saimo secured China Mobile International as the cornerstone investor, which committed to subscribe for HK$148.5 million worth of IPO shares.
The issuer expects to determine its offer price on Jan. 13 and disclose the allocations on Jan. 14. It will then start trading on the Hong Kong bourse on Jan. 15, according to a Tuesday filing.
Proceeds from the deal will be used to enhance research and development capabilities, develop new ICV testing, validation, and evaluation solutions, penetration into new industries, geographic expansion of the sales and marketing efforts, and working capital and other general corporate purposes.
CEB International, Citic Securities, China Galaxy International, ICBC, and several others are the joint bookrunners of the IPO.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。